Xarelto is a drug which is used to reduce the risk of stroke and blood clots in those with atrial fibrillation. Xarelto can be used to prevent or treat deep vein thrombosis or pulmonary embolism, and is used to prevent blood clots in those who have undergone knee or hip replacement surgery. Xarelto is often prescribed over Warfarin because it does not require regular blood monitoring, allows a more universal dosage and has no known adverse food interactions. Unlike Warfarin, a blood thinning drug which has been in use since 1954, there is no known antidote to excessive Xarelto bleeding.
While Bayer, the manufacturer of Xarelto, continues to maintain the drug’s safety, the black box warning on the drug may suggest otherwise. The Xarelto labeling includes two black box warnings; the first warns that patients who will undergo a spinal tap or receive spinal anesthesia while taking Xarelto could end up with long-term or permanent paralysis. The second warning informs patients who have non-valvular atrial fibrillation that discontinuing Xarelto could result in an increase in blood clot and stroke. A number of deaths have been associated with Xarelto as well as intracranial hemorrhage, gastrointestinal hemorrhage, stroke and blood clots.
Xarelto Internal Bleeding Lawsuit
According to a German newspaper, Xarelto internal bleeding lawsuits have been filed, although it is believed that number is currently less than ten. Virginia Stuntebeck recently filed a Xarelto internal bleeding lawsuit against Bayer and Johnson & Johnson, claiming she almost bled to death due from taking Xarelto. Stuntebeck is from Kentucky, and claims Xarelto is an unreasonably dangerous drug and that Bayer and Johnson & Johnson failed to adequately warn consumers regarding the risks of internal bleeding which, in some cases, can be irreversible. The FDA recently rejected Bayer’s application to expand the use of Xarelto for the treatment of acute coronary syndrome. This was the third refusal from the FDA to expand the approved uses of Xarelto.
Xarelto Paralysis Lawsuit
Xarelto affects the body’s natural clotting process; however a side effect of that process can be spinal or epidural hematomas. A hematoma is a solid swelling of clotted blood which can block the flow of blood, leading to a pulmonary embolism or stroke. When a hematoma occurs in the spinal area, paralysis can occur, making the patient eligible for a Xarelto paralysis lawsuit. In the patient’s guide to Xarelto, under the section which states the most important information patients should know about Xarelto, cautions to patients undergoing spinal or epidural anesthesia or spinal puncture procedures are stated. In fact, the Xarelto patient guide states that permanent paralysis may be the result when those taking Xarelto undergo a spinal procedure and develop a hematoma in the spinal area.
Hematomas or blood clots which develop in the spinal area can inhibit transmission of nerve impulses to and from the brain. Paralysis can cause the patient to lose all feeling and muscle control in the spinal area, leading to breathing difficulties, sexual dysfunction, urinary incontinence, and the inability to walk. Xarelto users who have any of the following issues are at a higher risk of developing Xarelto paralysis:
Currently take other blood thinning drugs
Have had a prior spinal surgery
Have current spinal problems
Are currently taking NSAIDs
Have an epidural catheter in their back
You may be eligible to file a Xarelto paralysis lawsuit if you were taking the drug, and had a spinal procedure which left you partially paralyzed, either for a considerable length of time or permanently. Filing a Xarelto paralysis lawsuit could entitle you to pursue compensation for current and future medical expenses as well as damages for pain and suffering.
Xarelto Death Lawsuit
In 2012, 58 deaths were associated with Xarelto, and in 2013, 72 deaths were associated with Xarelto. Just days ago a Xarelto death lawsuit was filed by the family of a Vermont man who suffered irreversible brain bleeding allegedly caused by Xarelto. The complaint was filed by the daughter of Thomas C. Dunkley, against Johnson & Johnson subsidiary, Janssen Pharmaceuticals and Bayer. The Xarelto death lawsuit claims Dunkley was prescribed Xarelto in July, 2012, for treatment of atrial fibrillation. Dunkley had used the drug for less than ten days when he suffered irreversible brain bleeding, eventually leading to his death. This Xarelto death lawsuit notes that on June 6, 2013, Bayer and Johnson & Johnson were cited by the FDA for distributing promotional material which was false or misleading due to the fact the materials minimized the potential Xarelto risks.
What are the Chances of Future Xarelto MDL or Xarelto Class Action Litigation?
While there are currently no Xarelto MDL (multi-district litigation) or Xarelto class action litigation suits, if more consumers continue to suffer serious, adverse reactions from the drug, it is likely those MDL’s and class action lawsuits will follow. When a large number of lawsuits are filed against a single manufacturer, they are often combined into multidistrict litigation in order to simplify the process and have the cases handled more quickly. Those whose lawsuit becomes a part of an MDL have their own lawyer and their lawsuit is handled as an individual case, however each lawsuit benefits from shared information and evidence.
Have there been Xarelto Deaths?
Could You Benefit From Speaking to a Xarelto Lawyer?
If you or a loved one suffered serious injury after taking Xarelto, you are encouraged to speak to an experienced Xarelto lawyer. Many who have already filed suit against Bayer and Janssen are alleging the companies failed to adequately warn patients and physicians of the potential dangerous bleeding side effects of the drug. There are also allegations that the companies marketed a defective drug, since there is no known antidote to excessive Xarelto bleeding. Speaking to a knowledgeable Xarelto lawyer will ensure your rights are protected and that you receive the compensation you are entitled to for the injuries you suffered after taking Xarelto.